SCHEMBL19687950

SCHEMBL19687950

CCC[C@@H](C)OC(=O)[C@H]1CCCN1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 1/20 0.47
PRCP P42785 3/20 0.46
TLR2 O60603 2/20 0.41
GPR88 Q9GZN0 2/20 0.37
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
IDO1 P14902 1/20 0.35
NOS2 P35228 2/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14315876 1.00 DPP7 (0.47) DPP7PRCPTLR2GPR88CYP1A2
SCHEMBL19687949 1.00 DPP7 (0.47) DPP7PRCPTLR2GPR88CYP1A2
SCHEMBL14887354 0.87 PRCP (0.44) DPP7PRCPTLR2CYP1A2CYP3A4
SCHEMBL14887236 0.87 PRCP (0.44) DPP7PRCPTLR2CYP1A2CYP3A4
SCHEMBL14887225 0.87 PRCP (0.44) DPP7PRCPTLR2CYP1A2CYP3A4
SCHEMBL19387299 0.84 PRCP (0.41) DPP7PRCPTLR2CYP1A2CYP3A4
SCHEMBL6987475 0.83 PRCP (0.48) DPP7PRCPTLR2GPR88CYP1A2
SCHEMBL7320977 0.83 DPP7 (0.37) DPP7PRCPTLR2CYP1A2CYP3A4
SCHEMBL16586221 0.83 PRCP (0.40) DPP7PRCPTLR2CYP3A4CYP2D6
SCHEMBL16585964 0.83 PRCP (0.40) DPP7PRCPTLR2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043447-A1 PEPTIDE-CONTAINING LINKERS FOR ANTIBODY-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. 2023-02-09 US disclosed
US-11135307-B2 Peptide-containing linkers for antibody-drug conjugates MERSANA THERAPEUTICS, INC. (US) 2021-10-05 US disclosed
US-20210106690-A1 PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. 2021-04-15 US disclosed
US-10603386-B2 Protein-polymer-drug conjugates MERSANA THERAPEUTICS, INC. (US) 2020-03-31 US disclosed
US-20180154018-A1 PEPTIDE-CONTAINING LINKERS FOR ANTIBODY-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. 2018-06-07 US disclosed
US-20170348424-A1 PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11135307-B2 Peptide-containing linkers for antibody-drug conjugates CD2BP2, DNPEP, LNPEP DPP7 145/4885PRCP 96/4885TLR2 3635/4885
US-20170348424-A1 PROTEIN-POLYMER-DRUG CONJUGATES PBRM1, CLTB, BRAP DPP7 2514/4885PRCP 149/4885TLR2 637/4885
US-20230043447-A1 PEPTIDE-CONTAINING LINKERS FOR ANTIBODY-DRUG CONJUGATES CD2BP2, DNPEP, LNPEP DPP7 145/4885PRCP 96/4885TLR2 3635/4885
US-20210106690-A1 PROTEIN-POLYMER-DRUG CONJUGATES PBRM1, CLTB, BRAP DPP7 2620/4885PRCP 213/4885TLR2 542/4885
US-10603386-B2 Protein-polymer-drug conjugates PBRM1, CLTB, BRAP DPP7 2537/4885PRCP 257/4885TLR2 532/4885
US-20180154018-A1 PEPTIDE-CONTAINING LINKERS FOR ANTIBODY-DRUG CONJUGATES CD2BP2, DNPEP, LNPEP DPP7 145/4885PRCP 96/4885TLR2 3635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.